Stephen J. Clarke is an oncologist based at Chris O’Brien Lifehouse in Sydney, NSW 2050. He works in cancer care and helps people manage the big, day-to-day challenges that can come with a new diagnosis, treatment changes, or side effects.
In practice, Stephen looks after a wide range of cancers. This includes lung cancers such as non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), lung adenocarcinoma, and EGFR positive lung cancer. He also works with people who have colorectal cancer, mesothelioma, pancreatic cancers, neuroendocrine tumours, and melanoma. Other conditions he commonly supports include prostate cancer, renal cell carcinoma, breast cancer, anal cancer, and bile duct (cholangiocarcinoma) cancers. At times, his patients may be dealing with rarer tumour types as well, like adrenocortical cancer.
Over time, he also supports patients with related health issues that can show up alongside cancer care. This can include symptoms like chronic pain, diarrhoea, and tiredness. It can also include problems such as obesity and osteoporosis, and blood clot concerns like venous thromboembolism (VTE). In some cases, he helps coordinate care where emergency reactions matter too, such as anaphylaxis.
Stephen’s work often involves getting the right diagnosis first. That can mean arranging a tissue biopsy, then using the results to guide the next steps. He also works with patients around major cancer treatments and procedures, including things like pancreatectomy and pancreaticoduodenectomy for suitable cases, and splenectomy where needed.
His approach is practical and focused on the whole picture. That means listening to what is happening for the patient right now, then working out a plan that fits their situation and their goals. Cancer care can be full of appointments and uncertainty, so he aims to keep things clear and grounded, especially when results or next steps are still coming through.
Stephen has training in oncology and cancer care, and stays up to date with improvements in how cancers are treated. Where appropriate, he also takes part in research and clinical trials, so some patients may have access to new options as they become available.
If a condition like Lynch syndrome is in the mix, he helps patients understand what that can mean for screening and family risk, alongside their current cancer care.
